Aceclofenac Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablets and other forms like Enteric-coated tablets, Dispersible tablets, Capsules, Topical formulations (gel, cream)
Available Strengths: 100mg and 200 mg
Reference Brands: Generic brands avaialble
Category:
Analgesic
Aceclofenac tablets inhibit cyclooxygenase enzymes (COX-1 and COX-2), reducing prostaglandin synthesis. They effectively relieve pain, inflammation, and joint stiffness in osteoarthritis and rheumatoid arthritis. Benefits include faster symptom relief, improved joint function, and reduced swelling, supporting mobility and quality of life when used as prescribed.
Aceclofenac tablets is available in Tablets and other forms like Enteric-coated tablets, Dispersible tablets, Capsules, Topical formulations (gel, cream)
and strengths such as 100mg and 200 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Aceclofenac tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Aceclofenac tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Aceclofenac tablets are regulated in the EU and US, supported by dossiers demonstrating safety, efficacy, and manufacturing quality following GMP standards. In the US, approval involves validation, safety assessments, and GMP compliance; however, aceclofenac is mainly used in compounded formulations. In the EU, CE marking certifies conformity with MDR standards for anti-inflammatory indications. These formulations undergo validation, stability testing, and audits, supported by comprehensive documentation including safety profiles, clinical data, and manufacturing practices. For licensing procedures, approved dossiers, and latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to quality aceclofenac products supporting inflammatory and pain management worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing